Migdal Insurance & Financial Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Migdal Insurance & Financial Holdings's BMY Position: Q3 2024 in Review
Migdal Insurance & Financial Holdings sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 660 shares — an estimated $27K sold.
Migdal Insurance & Financial Holdings first reported a position in BMY in Q4 2015 and held it in 19 quarters. The position peaked at $23M in Q4 2015. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- Migdal Insurance & Financial Holdings reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
- Migdal Insurance & Financial Holdings sold 660 Bristol-Myers Squibb shares in Q3 2024, an estimated $27K.
- Migdal Insurance & Financial Holdings first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 19 quarters.
- Migdal Insurance & Financial Holdings's Bristol-Myers Squibb position peaked at $23M in Q4 2015.
- 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2024, filed 4 Nov 2024.